BioSphere Medical Says Its Embosphere Microspheres Should Be The Preferred Agent For Uterine Fibroid Embolization
Tuesday, January 15, 2008; Posted: 12:26 PM
(RTTNews) - Tuesday, BioSphere Medical, Inc. (
BSMD |
news |
PowerRating |
PR
Charts ), a manufacturer and marketer of various medical applications products, revealed positive results of its study on Embosphere Microspheres for Uterine Fibroid Embolization.
The company said that Uterine Artery Embolization, or UAE, or UFE, performed using BioSphere's Embosphere Microspheres showed significantly better results in blocking the flow of blood from arteries that feed benign uterine fibroids, compared to procedures performed using Boston Scientific's Contour SE polyvinyl alcohol, or PVA, embolic administered in accordance with Boston Scientific's newly refined treatment protocol.
In Contour SE PVA microsphere group, treatment failure was seen in 29.6% of patients versus 3.8% of patients treated with Embosphere Microspheres. The company also said that 100% artery occlusion was achieved in 92.3% of the patients treated with Embosphere Microspheres, in comparison with only 66.7% of those treated with the PVA microspheres.
The company said that Embosphere Microspheres was the first embolic cleared by the FDA for UFE and is the most clinically studied spherical embolic. As a result of the favorable outcome of the studies, physicians would continue to show a strong, sustained preference for Embosphere.
Richard Faleschini, Chief Executive Officer of BioSphere commented, "Embosphere continues to outperform any spherical PVA embolic in its current formulation either from Boston Scientific or Terumo/Biocompatibles. We will continue to strive to increase our global market share position in UFE, and based upon studies such as the one we are reporting on today, believe we will be able to do so."
BSMD's shares are currently trading at $4.96, flat with its previous closing.
For comments and feedback: contact editorial@rttnews.com
Copyright(c) 2008 RealTimeTraders.com, Inc. All Rights Reserved
Morning Coffee with TradingMarkets -- Free Newsletter
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
